Investment fund based on blockchain technology

Genexi is a blockchain-based investment fund focused on financing prospective projects in the biotech industry

Public Sale starts in

Days
Hours
Minutes
Seconds

Join Genexi

Get Updates

Project presentation

Our Projects

Restet

Restet is our flagship project aimed at research and development of pharmaceuticals containing bacteriorhodopsin - a protein which is extensively used in the treatment of skin diseases, such as psoriasis.

It is a unique invention in modern molecular biocosmetology, which has received an issued patent.

Roadmap

Project
launch

September 2017

Private
pre-sale

January - March 2018

Main stage of
token sale

April - May 2018

GEN token
emission

May 2018

Restet
production release

May - June 2018

Scientific
research

September - December 2018

Token listing
on exchanges

June - July 2018

Production
scaling

June - August 2018

Production
scaling

June - August 2018

Token listing
on exchanges

June - July 2018

Further
R&D

September - December 2018

Restet
production release

May - June 2018

Events & Media

January - March 2018

Private
pre-sale stage

Token price: $0.1
Bonus tokens: 25%

 
 

 

BTC/ BCH / BTG /ETH / LTC / DASH / XMR

2 – 9 April 2018

Main stage
of tokensale

Token price: $0.1
Bonus tokens: 17%

Extra bonuses for investments of $200 000 or more
Bonus tokens: 25%

BTC/ BCH / BTG /ETH / LTC / DASH / XMR

10 – 17 April 2018

Main stage
of tokensale

Token price: $0.1
Bonus tokens: 9%

Extra bonuses for investments of $200 000 or more
Bonus tokens: 17%

BTC/ BCH / BTG /ETH / LTC / DASH / XMR

18 – 25 April 2018

Main stage
of tokensale

Token price: $0.1
Bonus tokens: 5%

Extra bonuses for investments of $200 000 or more
Bonus tokens: 9%

BTC/ BCH / BTG /ETH / LTC / DASH / XMR

26 April – 3 May 2018

Main stage
of tokensale

Token price: $0.1
Bonus tokens: 0%

Extra bonuses for investments of $200 000 or more
Bonus tokens: 5%

BTC/ BCH / BTG /ETH / LTC / DASH / XMR

In order to participate in Genexi token sale, the users need to register on the website https://genexi.io and get access to their account. We will be accepting BTC, BCH, BTG, ETH, LTC, DASH and XMR as means of payment during our token sale.

All of the deposits will be converted into US dollars, according to the spot exchange rate on the date and the corresponding amount of tokens will be sent to your crypto wallets.

The main stage of GEN token sale starts at 12:00 on 2nd April 2018 and ends at 12:00 GMT on 3rd May 2018 or at the moment of reaching the hard cap of 30 000 000 $.

Soft cap: $10M
Hard cap: $30M

All unsold tokens will be burned after the main stage of token sale.

Distribution of funds collected

$15 000 000

Distribution of funds collected

$30 000 000

Our team

ADVISORS

Sergey Tiurin

MEDICAL ADVISOR

Having more than 35 years of medical experience, he is an author of multiple research papers on topics including bioorganic and protein chemistry. Tiurin’s career started in 1982 at State Research Institute of Genetics and Selection of Industrial Microorganisms of the National Research Center, where he researched the chemical structure of the bendotoxin protein. After the graduation, he started a project on biopreparation of endotoxin with extended spectrum of insecticidal activity, successfully collaborating with the US Department of Agriculture. In 2008, he founded an innovative company BIOS, whose main purpose was to create a new product on the basis of bacteriorhodopsin protein, which resulted in the developmnent of a new highly effective medicine to treat skin diseases.

Anti Danilevski

ADVISOR

As a founder of KICKICO platform, he leads the biggest Russian crowdfunding community as well as other online communities. Anti brings over 11 years of experience and in crowdfunding, online community-building, and IT to our project.

Alexander Novoselov

MEDICAL ADVISOR

Member of the Moscow Society of Dermatology and Cosmetology. Holds a Masters degree in Medicine.

Philip McMaster

ADVISOR

Co-Founder of the Republic of Conscience and World Sustainability Project. Philip has a diverse background in sales, marketing and corporate strategy - building on experience from aerospace to acting, publishing to sports, television to blockchain and media to academia.

CORE TEAM

Alexey Zhelyaskov

FOUNDER, CEO

President of JFSC Atlant with over 12 years of professional experience in investment management.

Alexey Kirillov

CO-FOUNDER

7 years of working experience in commercial finance and real estate. Cryptocurrency portfolio manager and blockchain enthusiast.

Roman Gilvanov

MANAGING DIRECTOR

CEO at IronFX Russia LLC - one of the largest European FX brokerages with more than 80 branch offices around the world.
Linkedin

Alexey Siniukov

HEAD OF STRATEGY

Former head of strategy in largest Russian private equity funds. His expertise covers seed, early-, and late-stage Venture Capital investment rounds, as well as the follow-on investments in privately held companies.

Anton Sklovets

HEAD OF RESEARCH

15+ years of professional experience in trading equities and derivative instruments in global equity markets. Anton graduated the Financial University under the Government of the Russian Federation and holds MSc in Finance.

Anton Nizhenkov

INVESTMENT ANALYST

Anton became part of Genexi in October 2016, his daily focus is research and managing the quantitative team. Prior to joining Genexi, he worked for the leading Russian pharmaceutical companies where he was responsible for the investment side of business. Holds a qualification certificates of financial market specialist 1.0 and 5.0. A prodigy in the ICO analysis.

Andrew Zharkov

HEAD OF FINANCE

More than 10 years of working experience in financial sector. Acclaimed expert in accounting and cryptocurrency mining.

Jacques Miabouna

STRATEGY CONSULTANT

Experienced professional in marketing and sales, worked for several international companies. Held several different positions in The Prince’s Trust charity fund.

Anna Fursova

MARKETING MANAGER

Held various roles within PR and Marketing for international compnaies. Former Head of Marketing and Communication.

Olga Fomina

MARKETING MANAGER

Skilled specialist in digital marketing with a proven track record of successful implementation of bespoke marketing solutions.

The global biotechnology market size was estimated at

$414,5 billion in 2017 and is expected to reach - $727,1 billion by 2025.

Subscribe to newsletter



mail: info@genexi.io / tel: +7 (495) 120-99-77